Re: Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain shirota on the murine orthotopic bladder tumor MBT-2 [2] (multiple letters)

Journal of Urology

Volumn 168, Issue 1, 2002, Pages 199-200

  Takahashi, T ^b   Kushiro, A ^b   Nomoto, K ^b   Uchida, K ^b   Morotomi, M ^b   Yokokura, T ^b   Akaza, H ^b   Brandau, Sven ^a,b   Böhle, Andreas ^a,b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BIOLOGICAL RESPONSE MODIFIER; GAMMA INTERFERON; IMMUNOSTIMULATING AGENT; LC 9018; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; IMMUNE RESPONSE; IMMUNOSTIMULATION; LACTOBACILLUS CASEI; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0036286039     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)64870-7     Document Type: Letter

References (5)

1. Soloway M.S. Intravesical and systemic chemotherapy of murine bladder cancer Cancer Res 37 1977 2918
2. Günther J.H. Jurczok A. Wulf T. Brandau S. Deinert I. Jocham D. Optimizing syngeneic orthotopic murine bladder cancer (MB49) Cancer Res 59 1999 2834
3. Ratliff T.L. Ritchey J.K. Yuan J.J.J. Andriole G.L. Catalona W.J. T-cell subsets required for intravesical BCG immunotherapy for bladder cancer J Urol 150 1993 1018
4. Brandau S. Riemensberger J. Jacobsen M. Kemp D. Zhao W. Zhao X. NK cells are essential for effective BCG immunotherapy Int J Cancer 92 2001 697
5. Riemensberger J. Böhle A. Brandau S. IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer Clin Exp Immunol 127 2002 20